IROA Technologies

The page covers metabolomics solutions and standards, including metabolic profiling kits, isotopic analysis, mass spectrometry libraries, and data tools for research.

The page covers identifying and validating metabolite-based biomarkers through clinical metabolomics.

Metabolomics normalization reduces technical variation and improves reproducibility in scientific studies.

The page describes a semi-targeted metabolomics analysis framework covering metabolic profiling, isotopic ratio analysis, and internal standards.

The company uses internal standards to produce clean, accurate, and reproducible datasets.

For information contact info@iroatech.com or 734-265-0884

The metabolomics workflow corrects suppression losses and normalization variances to support batch-to-batch reproducibility.

IROA Technologies highlights a *Nature Communications* publication featuring its **TruQuant Workflow**, a key innovation in metabolomics. The study, *Ion Suppression Correction and Normalization for Non-Targeted Metabolomics*, demonstrates advancements in AI-powered data validation through collaboration with **Bioz, Inc.** The workflow improves accuracy in metabolomic analysis, addressing challenges in ion suppression—a critical bottleneck in large-scale metabolite profiling.

Mar 2025NewswireNews article

Cambridge Isotope Laboratories, Inc. (CIL) collaborates with IROA Technologies LLC to develop and distribute IROA Biochemical Quantitation Kits globally. These kits enable metabolic profiling of cell populations and biological samples using advanced analytical tools. The partnership leverages CIL’s expertise in stable isotopes and IROATECH’s innovation in metabolic analysis.

Oct 2016BioSpaceNews article

Sigma-Aldrich partners exclusively with IROA Technologies to distribute its **Mass Spectrometry Metabolite Library of Standards™ (MSMLS)** globally. The deal combines IROA’s metabolite reference standards and software with Sigma-Aldrich’s eCommerce and supply chain infrastructure. This collaboration expands access to high-precision analytical tools for life science and research applications.

Sep 2015PR NewswireNews article

IROA Technologies partners with the University of Florida to identify biomarkers for liver cancer and other liver diseases. The collaboration leverages IROA’s patented software and expertise alongside UF’s Clinical and Translational Science Institute Biorepository, which holds a diverse collection of normal and diseased liver tissues. The project aims to advance early detection and treatment research for liver-related conditions.

Aug 2014Drug Discovery NewsNews article